Treatments that target the renin-angiotensin-aldosterone system (RAAS) don’t improve outcomes in adult patients hospitalized with acute COVID-19. Three separate trials of different RAAS-related ...

Recent cohort studies report that patients with coronavirus disease 2019 (COVID-19) and hypertension or diabetes have an increased risk of respiratory failure and death; such patients are often ...

Angiotensin II receptor antagonists are agents used to modify the renin-angiotensin-aldosterone system (RAAS) through blocking angiotensin receptors. This has the effect of lowering blood pressure.

In a recent study posted to the medRxiv* preprint server, researchers conducted an umbrella review and meta-analysis of the renin-angiotensin-aldosterone system (RAAS) inhibitors' impact on ...

Unique Characteristics of Hypertension in Blacks That Influence BP Responses to Drugs That Block the Renin-Angiotensin Activating System (RAAS) Blockade of the RAAS in Blacks for Cardiovascular and ...

A portal hidden on the Dark Web is responsible for the small deluge of recent PadCrypt ransomware versions that have been spotted almost on a monthly basis in the past year. Besides infosec experts ...

Angiotensinogen is produced mainly in the liver and fat cells, in response to poor perfusion, and acts as a pro-signal in the complex downstream renin–angiotensin–aldosterone (RAAS) system.